Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRaG2.0 Rechallenge in PD-1/PD-L1 Resistant Solid Tumors
NCT05530200Phase 2Unknown
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Sep 2022
- Primary completion
- Dec 2024
01
Overview
Phase 2, open-label trial in solid tumor, sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoint: Objective Response Rate up to 3 years. Status: unknown.
02
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05530200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05530200.